Visit Our Coronavirus (COVID-19) Resource Section ⇒

X

Dr. Andres Alarcon

(757) 668-7238
Practice
Board Certifications

American Board of Pediatrics

Pediatric Infectious Disease

Education

Medical School: Universidad Autonoma De Guadalajara

Residency: Sinai Hospital of Baltimore

Fellowship: George Washington University

Bio

Dr. Alarcon's background in international work, and public health initiatives has allowed him to work in diverse environments. This experience has taught him to approach each family with respect, ultimately striving for family-oriented care.

Clinical Interests
  • Travel Medicine
  • Congenital infections
  • Respiratory infections
  • Encephalitis
  • Vector-borne infections
  • Global Health
Research
  • Epidemiology of maternal and pediatric infectious diseases (congenital infections)
  • Epidemiology of vector-borne and zoonotic pathogens
  • Clinical trials in pediatric infectious diseases
  • Community and global public health initiatives
Publications

1. Andrés Alarcón, Mackenzie Morgan, Susan P. Montgomery, Louis Scavo, Edward C.C. Wong, Andrea Hahn, Barbara Jantausch. Diagnosis and Treatment of Congenital Chagas Disease in a Premature Infant. Journal of Pediatric Infectious Diseases, 2016 Jul 27. 

2. Kumar Parvathi, Alarcón Andrés. First Ebola, Now Lassa! Pediatric Infectious Diseases Society News Article (PIDSNews). March 31, 2016. https://www.pids.org/news/511-first-ebola-now-lassa.html

3. Alarcón Andrés. FDA, Center for Drug Evaluation and Research, Division of Antiviral Products. Approval of Tenofovir/Emtricitabine (Truvada) Fixed dose combination tablets for HIV-1 infections in pediatric patients weighing at least 17 kg to less than 35 kg, and able to swallow a whole tablet. February, 2016. https://www.fda.gov/downloads/Drugs/.../DevelopmentResources/UCM497204.pdf

4. Alarcón Andrés. FDA, Center for Drug Evaluation and Research, Division of Antiviral Products. Pediatric approval of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (Genvoya) for HIV-1 in pediatric patients 12 years old to 17 years old. August, 2015 www.accessdata.fda.gov/drugsatfda_docs/nda/2015/207561Orig1s000MedR.pdf

5. Alarcón Andrés, Shetty Avinash, Gedalia Abraham. Septic Arthritis in Children: Clinical Update, chapter 4, Infections and the Rheumatic Diseases 1st edition. Springer International, USA. 2019

6. Alarcón Andrés, Bégué Rodolfo. Candida Arthritis, chapter 23, Infections and the Rheumatic Diseases 1st edition. Springer International, USA. 2019.

7. Alarcón Andrés, Bernhard L. Wiedermann. Relapsing Fever, chapter 277. Rudolph’s Pediatrics, 23rd edition. McGraw-Hill Education, USA. 2018.

8. Alarcón Andrés, Jantausch Barbara. Listeriosis, chapter 261. Rudolph’s Pediatrics, 23rd edition. McGraw-Hill Education, USA. 2018.

9. Collaborator, Andrés Esteban Alarcón. Escherichia Coli Diarrhea, Shigella infections, Norovirus, Astrovirus, Lymphocytic Choriomenigitis, Bocavirus, Chikunguya, Leptospirosis. In: Kimberlin DW, Brady MT, Jackson MA, Long SS, eds. Red Book: 2018 Report of The Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics; 2018

10. Collaborator, Andrés Esteban Alarcón. Escherichia Coli Diarrhea, Salmonella infections, and Shigella infections. In: Kimberlin DW, Brady MT, Jackson MA, Long SS, eds. Red Book: 2015 Report of The Committee on Infectius Diseases. Elk Grove Village, IL: American Academy of Pediatrics; 2015: 343-347; 695-701; 706-709

Community Involvement

Médecins Sans Frontières: Volunteer Specialist Team in Telemedicine, Pediatric Infectious Diseases.

A Note from Dr. Alarcon

"Children’s Hospital of The King’s Daughters is keenly focused on the public health of the community and beyond. Public health awareness and being a free standing children's hospital is what attracted me to collaborating with the talented health care team at CHKD."

(757) 668-7238